Impact of PCSK9 inhibitors in glycaemic control and new-onset diabetes

Impact of PCSK9 inhibitors in glycaemic control and new-onset diabetes

Abstract Background The diabetogenic effect of statins has been well established by clinical trials, Mendelian randomisation studies and meta-analyses. According to large clinical trials, PCSK9 inhibitors (PCSK9i) have no deleterious impact on glucose metabolism. However, few real-life studies have...

Full description

Bibliographic Details
Main Authors: Ana M. González-Lleó, Rosa M. Sánchez-Hernández, Núria Plana, Daiana Ibarretxe, Pere Rehues, Josep Ribalta, Dídac Llop, Ana M. Wägner, Lluís Masana, Mauro Boronat
Format: Article
Language:English
Published: BMC 2024-01-01
Series:Cardiovascular Diabetology
Subjects:
New-onset Diabetes Mellitus
Prediabetes
PCSK9 inhibitors
Real-life study
Hyperglycaemia
Familial hypercholesterolemia
Online Access:https://doi.org/10.1186/s12933-023-02077-y

Internet

https://doi.org/10.1186/s12933-023-02077-y

Similar Items